News

Whistleblower Sarah Behnke's lawsuit leads to a $290 million judgment against CVS Caremark for overcharging Medicare on ...
Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the ...
A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...
A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the ...
A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...
CVS Caremark, CVS Health’s (NYSE:CVS) pharmacy benefit manager, has been ordered by a federal judge to pay $289.9M in damages ...
Notably, the case came from a whistleblower lawsuit filed by Sarah Behnke, a former Medicare Part D actuary at Aetna, who ...
A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a long-running whistleblower case. | A ...
CVS Caremark, the pharmacy benefit management division of Woonsocket, R.I.-based CVS Health, stands accused of improperly reporting Medicare generic drug prices to CMS, according to a STAT report.
CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health insurer Aetna and the major pharmacy benefits manager Caremark.
CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health insurer Aetna and the major pharmacy benefits manager Caremark.